Enrolling Clinical Research Studies

Celiac Disease on a Gluten-Free Diet

Contraceptive Study

COVID-19 AND INFLUENZA IN HEALTHY INDIVIDUALS Vaccine Study

COVID-19 treatment in Nonhospitalized Participants

DIABETIC PERIPHERAL NEUROPATHIC PAIN

Non-Hormonal Pharmacotherapies Among Individuals Treated for Both

Prevention of COVID-19

Treatment of Active Celiac Disease in Subjects Attempting a Glute

TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA-LIKE ILLNESS (FLU)

Uterine Fibroids or Endometriosis women who are at Risk for Pregn

Uterine Fibroids or Moderate to Severe Pain Associated with Endom

Diabetes
DIABETIC PERIPHERAL NEUROPATHIC PAIN

DIABETIC PERIPHERAL NEUROPATHIC PAIN

A PHASE 2 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF RTA 901 IN PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN

» Study Details | Apply for the Study

Future Studies
Upcoming Studies for Men & Women

Upcoming Studies for Men & Women

Click to add your name to the waiting list for upcoming studies. We will alert you when we begin a new study. Please provide your email address if possible.

*PLEASE DO NOT CALL THE STUDY CENTER UNLESS YOU ARE CONTACTED FIRST*

» Study Details | Apply for the Study

Gastroenterology
TAK-062-2001 Treatment of Active Celiac Disease in Subjects Attempting a Gl

TAK-062-2001 Treatment of Active Celiac Disease in Subjects Attempting a Gl

Participants are needed for the ILLUMINATE-062 Study, which is looking at the safety and effectiveness of an investigational medication designed to break down gluten in the stomach compared with placebo in those with celiac disease who are on a gluten-free diet. The study will evaluate how well the investigational medication reduces celiac-related symptoms and intestinal damage due to gluten exposure.   Participants who have been diagnosed with celiac, which was confirmed by a biopsy, and have been on a gluten-free diet for at least 12 months are needed. Study-related care is provided at no cost, and a travel stipend may be provided.

» Study Details | Apply for the Study

Prevention of Gluten-Specific T Cell Activation in Subjects with Celiac Dis

Prevention of Gluten-Specific T Cell Activation in Subjects with Celiac Dis

The ILLUMINATE-101 clinical research study is evaluating the safety and effectiveness of an investigational medication designed to reduce or eliminate the negative immune response to gluten in adults with celiac disease and participants are needed.

» Study Details | Apply for the Study

Women’s Health
Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safe

Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safe

A Phase 3, Multicenter, Open-Label, Single Arm Study of MR-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety

» Study Details | Apply for the Study

Combination Therapy in Women with Uterine Fibroids or Endometriosis who are

Combination Therapy in Women with Uterine Fibroids or Endometriosis who are

Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women with Uterine Fibroids or Endometriosis who are at Risk for Pregnancy

» Study Details | Apply for the Study

Uterine Fibroids or Moderate to Severe Pain Associated with Endometriosis

Uterine Fibroids or Moderate to Severe Pain Associated with Endometriosis

Open-Label Study to Evaluate Bone Mineral Density with Long-Term Use of Relugolix Combination Tablet in Premenopausal Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids or Moderate to Severe Pain Associated with Endometriosis

» Study Details | Apply for the Study

Non-Hormonal Pharmacotherapies Among Individuals Treated for Bothersome Vas

Non-Hormonal Pharmacotherapies Among Individuals Treated for Bothersome Vas

Non-Hormonal Pharmacotherapies Among Individuals Treated for Bothersome Vasomotor Symptoms

» Study Details | Apply for the Study

ID
 

TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA-LIKE ILLNESS

A PHASE 2B DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF THE EFFICACY AND SAFETY OF NORKETOTIFEN IN THE TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA-LIKE ILLNESS (ILI)

» Study Details | Apply for the Study

Treatment of COVID-19 in Nonhospitalized Participants

Treatment of COVID-19 in Nonhospitalized Participants

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GS-5245 for the Treatment of COVID-19 in Nonhospitalized Participants

» Study Details | Apply for the Study

 

A Study to Evaluate the Efficacy and Safety of VYD222 for Prevention of COV

A Study to Evaluate the Efficacy and Safety of VYD222 for Prevention of COVID-19 (CANOPY)

» Study Details | Apply for the Study

COVID-19 AND INFLUENZA IN HEALTHY INDIVIDUALS Vaccine Study

COVID-19 AND INFLUENZA IN HEALTHY INDIVIDUALS Vaccine Study

COVID-19 AND INFLUENZA IN HEALTHY INDIVIDUALS Combo Vaccine Study

» Study Details | Apply for the Study

Powered By RealTime-CTMS Clinical Trial Management System